glycopyrrolate

Preferred Label : glycopyrrolate;

MeSH definition : A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.;

MeSH synonym : Glycopyrronium Bromide; Bromide, Glycopyrronium; Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide;

CISMeF synonym : glycopyrronium bromide;

DeCS synonym : Glycopyrronium Bromide;

MeSH hyponym : NVA237; NVA 237; NVA-237; Bromide, Glycopyrronium; Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide;

MeSH CAS label : pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide;

MeSH Related Number : 596-51-0 (Glycopyrrolate); A14FB57V1D;

Registry Number MeSH : 596-51-0;

Wikipedia link : https://en.wikipedia.org/wiki/Glycopyrronium bromide;

Codes EINECS : 209-887-0;

Is substance : O;

UNII : V92SO9WP2I;

InChIKey : VPNYRYCIDCJBOM-QQTWVUFVSA-M;

Details

Origin ID

D006024;

UMLS CUI

C0017970;

ATC code(s)
- glycopyrronium bromide [ATC Code]
ATC code(s)
- formoterol and glycopyrronium bromide [ATC Code]
- formoterol, glycopyrronium bromide and beclometasone [ATC Code]
- formoterol, glycopyrronium bromide and budesonide [ATC Code]
- glycopyrronium [ATC Code]
- glycopyrronium [ATC Code]
- glycopyrronium and psycholeptics [ATC Code]
- glycopyrronium bromide [ATC Code]
- indacaterol and glycopyrronium bromide [ATC Code]
- indacaterol, glycopyrronium bromide and mometasone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- glycopyrronium bromide [Substance BNPC]
Pharmacological action(s)
- adjuvants, anesthesia [MeSH Descriptor]
- muscarinic antagonists [MeSH Descriptor]
Record concept(s)
- Glycopyrronium [MeSH concept]
- NVA237 [MeSH concept]
- glycopyrrolate [MeSH concept]
Related MeSH Supplementary Concept(s)
- budesonide-glycopyrrolate-formoterol fumarate drug combination [MeSH Supplementary Concept]
- glycopyrronium tosylate [MeSH Supplementary Concept]
- hexopyrronium [MeSH Supplementary Concept]
- indacaterol-glycopyrronium combination [MeSH Supplementary Concept]
- oxypyrronium bromide [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Glycopyrrolate (product) [Inactive SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Glycopyrrolate [NCIt concept]
- Glycopyrrolate (product) [Inactive SNOMED CT concept]
- Glycopyrronium bromide [ICD-11 Extension code]
- Glycopyrronium bromide (substance) [SNOMED CT concept]
- glycopyrrolate [SNOMED Notion]
- glycopyrronium bromide [Substance BNPC]
- glycopyrronium bromide [SNOMED Notion]
Validated automatic mappings to BTNT
- glycopyrronium bromide [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients